Research on preparing for pandemics and controlling viral outbreaks
Pandemic preparedness research and biocontainment infrastructure at The Rockefeller University
This study is looking at how certain viruses, like chikungunya, affect our immune system to help create better treatments and vaccines for future pandemics, so everyone can stay healthier and safer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rockefeller University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10611639 on NIH RePORTER |
What this research studies
This research focuses on enhancing our preparedness for pandemics by investigating various viruses, including chikungunya and other alphaviruses. The team at Rockefeller University employs advanced techniques to study how these viruses interact with the immune system, particularly through the development of neutralizing antibodies. By understanding these interactions, the research aims to identify effective antiviral agents and improve biocontainment strategies. Patients may benefit from new treatments and vaccines developed from these findings.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals at risk for infections caused by alphaviruses and other related viruses.
Not a fit: Patients with non-viral infections or those not at risk for the specific viruses being studied may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved antiviral therapies and vaccines that protect against viral infections.
How similar studies have performed: Previous research on antiviral agents and vaccines for similar viruses has shown promising results, indicating a potential for success in this area.
Where this research is happening
New York, United States
- Rockefeller University — New York, United States (Active)
Researchers
- Principal investigator: O'connor, Timothy — Rockefeller University
- Study coordinator: O'connor, Timothy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.